It has been shown by previous studies that silencing mutant ATXN3 in SCA3/MJD animal models is effective in slowing down the disease progression(Rodriguez-Lebron et al. 2013; Nobrega et al. 2013; Nobre et al. 2022). The gene discussed is ATXN3; the disease is Spinocerebellar ataxia type 3.